Influence of cytochrome P450 polymorphisms on the antiplatelet effects of prasugrel in patients with non-cardioembolic stroke previously treated with clopidogrel

This randomized double-blind crossover study aimed to investigate the influence of cytochrome P450 (CYP) 2C19 polymorphisms on the antiplatelet effects of prasugrel in patients with non-cardioembolic stroke treated with clopidogrel. Patients received clopidogrel 75 mg/day for > 4 weeks. Subsequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitazono, Takanari, Ikeda, Yasuo, Nishikawa, Masakatsu, Yoshiba, Satoshi, Abe, Kenji, Ogawa, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182384/
https://www.ncbi.nlm.nih.gov/pubmed/30074128
http://dx.doi.org/10.1007/s11239-018-1714-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182384/
https://www.ncbi.nlm.nih.gov/pubmed/30074128
http://dx.doi.org/10.1007/s11239-018-1714-2

Ejemplares similares